Gnathodiaphyseal dysplasia (GDD) is a rare skeletal syndrome characterized by bone fragility, sclerosis of tubular bones, and cemento-osseous lesions of the jawbone. By linkage analysis of a large Japanese family with GDD, we previously mapped the GDD locus to chromosome 11p14.3-15.1. In the critical region determined by recombination mapping, we identified a novel gene (GDD1) that encodes a 913-amino-acid protein containing eight putative transmembrane-spanning domains. Two missense mutations (C356R and C356G) of GDD1 were identified in the two families with GDD (the original Japanese family and a new African American family), and both missense mutations occur at the cysteine residue at amino acid 356, which is evolutionarily conserved among human, mouse, zebrafish, fruit fly, and mosquito. Cellular localization to the endoplasmic reticulum suggests a role for GDD1 in the regulation of intracellular calcium homeostasis.
after tooth extraction, and exposure of the lesions into the oral cavity. Extragnathic skeletal changes consist of generalized coarse bony trabeculae and gross thickening of the diaphyseal cortices of long bones (fig. 1C and 1D) . This syndrome was named "hereditary gnatho-diaphyseal sclerosis" (Akasaka et al. 1969) , because it was distinguished from known systemic bone diseases by coincidence of bone fragility, sclerosis of tubular bones, cemento-osseous lesions of the jawbone, and no abnormality in nonskeletal tissues. In 1985, Levin et al. independently described three families-whose condition shared many features with that reported by Akasaka et al.- as having "osteogenesis imperfecta with unusual skeletal lesions" (MIM 166260) (Levin et al. 1985) . Sporadic cases with similar clinical manifestations have also been reported (Colavita et al. 1984; Nishimura et al. 1996) . More recently, Riminucci et al. proposed to name this disease entity "gnathodiaphyseal dysplasia (GDD)," because osteosclerosis is not a feature of the jaw lesions of these patients (Riminucci et al. 2001) .
By linkage analysis of the Japanese family reported by Akasaka et al., we previously mapped the GDD locus to a 8.7-cM interval on chromosome 11p14.3-15.1, flanked by the recombinant markers D11S1308 and
Figure 1
GDD phenotype and mutations. A, Affected female from Japanese family at age 16 years; facial deformity characteristic of the GDD phenotype is shown. B, Three-dimensional image of computed tomography. The image shows jaw lesions occupying alveolar processes. Projections around teeth (asterisk) are metal artifacts caused by teeth fillings. C, D, Radiographs of upper and lower limbs showing diaphyseal cortical thickening of tubular bones (arrows). E, Physical map of the GDD critical region and genomic structure of GDD1. Exons (filled boxes) and UTRs (gray box) are shown. F, Sequence analysis showing heterozygous T-to-C and T-to-G changes in the codon for Cys 356 in affected members of the Japanese and African American families, respectively. SSCP patterns show cosegregation of mutant alleles (mu) with the disease phenotype. Individuals available for analyses are indicated (arrows). D11S930, where no bone-disease loci have been mapped (Tsutsumi et al. 2003) . On the basis of data from the University of California-Santa Cruz (UCSC) genome browser (UCSC Genome Bioinformatics Web site), the GDD critical region was shown to contain eight known genes (NAV2, HTATIP2, PRMT3, SLC6A5, NELL1, SLC17A6, FANCF, and GAS2) (fig. 1E ). By use of DNA samples from the Japanese family, these genes were screened for mutations by direct DNA sequencing with primer pairs that amplified all exons and exon-intron boundaries, but no mutations were detected.
In a further search for GDD candidate genes, we prioritized uncharacterized ESTs (expressed sequence tag sequences) that mapped to the critical region. A cDNA clone sequence AL833271 from skeletal muscle had a size of ∼6.7 kb, exhibited the polyadenylation signal (AATAAA) at the 3 end, and included an ORF of 2,742 bp encoding a protein of 913 amino acids, with a molecular mass of 107.20 kDa. A human skeletal muscle cDNA was amplified by 5 rapid amplification of cDNA ends (RACE) (Invitrogen), revealing that AL833271 was a full-length cDNA sequence. We named this gene "GDD1" (GenBank accession number AB125267). Aligning the UCSC July 2003 human genome assembly (UCSC Genome Bioinformatics Web site) with AL833271 revealed that GDD1 consisted of 22 exons and spanned ∼90 kb of genomic DNA ( fig. 1E ). The initiation and stop codons (ATG and TAA) were present in exons 1 and 22, respectively.
Oligonucleotide primers were designed to amplify and directly sequence the 22 exons, along with the flanking exon-intron boundaries (table A1 [online only]). Screening DNA from the Japanese family revealed that 14 affected members were heterozygous for a missense mutation in exon 11 at codon 356 (C356R; TGTrCGT), whereas 8 unaffected members had no mutation. Also, DNA sequencing in two affected members, but not in two unaffected members, from a new family of African American origin with GDD revealed another missense mutation at the same codon 356 (C356G; TGTrGGT). SSCP analysis confirmed that mutant alleles of GDD1 cosegregated with the disease phenotype in each family ( fig. 1F ). Neither of these two mutations was found in 488 Japanese or 80 African American control individuals.
The GDD1 protein showed no significant similarity to any other known protein or protein classes. However, amino acid sequence analysis using the helix-prediction program TMpred suggested that GDD1 contains eight transmembrane-spanning domains, with the N-and Ctermini located in the cytosol ( fig. 2A and 2B ). MOTIF and PSORT II also predicted five putative N-glycosylation sites and a potential endoplasmic reticulum (ER) retention signal (Teasdale and Jackson 1996) at the Cterminus (AKST), respectively ( fig. 2C ). On the other hand, BLAST analysis showed potentially orthologous sequences in zebrafish, fruit fly, and mosquito, indicating that the GDD1 protein is evolutionarily conserved. Mouse GDD1 (mGDD1) cDNA was isolated from mouse skeletal muscle cDNA (Clontech) and completed by RT-PCR by use of a mouse genome sequence with high homology to human GDD1 (hGDD1), which was identified through Ensembl (Ensembl Genome Browser Web site). The protein predicted from mGDD1 cDNA sequence shared 79% amino acid identity with the human GDD1 protein (hGDD1). Multiple sequence alignment of hGDD1 with its orthologs revealed that the eight cysteine residues at positions 342, 353, 356, 360, 369, 601, 606 , and 804 in the putative extracellular loops were absolutely conserved in all species ( fig. 2C ). These cysteine residues are expected to play an important role in the formation of intrachain disulfide bonds that are crucial for an appropriate tertiary structure of the hGDD1 protein, and the mutations of C356R and C356G probably compromise the conformation ( fig.  2B ).
The pattern of tissue expression was determined by a 581-bp fragment corresponding to the 3 UTR of hGDD1 cDNA, hybridized to a human Multiple Tissue Northern Blot (Clontech). Two major transcripts of ∼7.5 and ∼4.5 kb were detected in skeletal muscle, heart, and pancreas ( fig. 3A) . Since affected tissues were not represented on this blot, we examined levels of hGDD1 gene expression in explant cultures of normal human osteoblasts and periodontal ligament cells, as well as in nonskeletal tissues (Human Total RNA Master Panel [Clontech] ), by RT-PCR analysis. Expression of hGDD1 was detected in brain, heart, kidney, lung, and skeletal muscle at usual conditions (30 cycles) and was detectable after 40 cycles in explant cultures of osteoblasts and periodontal ligament cells, as well as the other tissues shown in figure 3B . Quantitative real-time RT-PCR analysis of various tissues derived from one mouse aged 8 wk revealed that mGDD1 was highly expressed in bone tissues, such as calvaria, femur, and mandible ( fig. 3C ).
Although this result appears to be in contrast with the low level of hGDD1 gene expression in human osteoblasts, we believe that the discrepancy in expression level might arise from differences in the samples used (explant cultures after three or four passages versus fresh bone tissues). The expression profile in vivo could not be reproduced completely in explant cultures.
To search the potential impact of the identified mutations, we transfected COS-7 cells with a plasmid expression vector containing the wild-type or mutant fulllength hGDD1 cDNA tagged with V5 epitope at its 3 end. On reducing SDS-PAGE and western blot analysis, anti-V5 antibody detected a band migrating at ∼110 kDa in the whole-cell lysate of each transfectant ( fig. 4A ). The band size was consistent with the predicted molec-
Figure 2
Characterization of the human GDD1 protein. A, The hydrophobic profile of the human GDD1 protein, which indicates that it contains eight potential transmembrane domains. B, Predicted membrane topology of the human GDD1 protein. The locations of the Nglycosylation sites (projections), the eight cysteine residues absolutely conserved in all species (C), the potential ER retention signal (gray box), and the mutated cysteine residue are shown. C, ClustalW multiple sequence alignment of GDD1 orthologs. Protein similarity between the GDD1 orthologs is relatively high, with the human protein 79%, 56%, 40%, and 41% identical to the mouse, zebrafish, fruit fly, and mosquito, respectively. The alignment shows that the eight cysteine residues in the putative extracellular loops are absolutely conserved in all species (highlighted in black). The predicted transmembrane domains (boxed), the putative N-glycosylation sites (red), and the potential ER retention signal (blue) are indicated. Identical (*), strictly conserved (:), and conserved (.) sites are indicated below the ClustalW alignment of GDD1 orthologs. ular mass from the hGDD1-V5 cDNA sequence. Immunofluorescent staining of transfected cells with anti-V5 antibody showed that the wild-type hGDD1 protein formed a distinct reticular pattern around the nucleus and colocalized with calreticulin, an ER-specific marker (Smith and Koch 1989) (fig. 4B ). It further showed that cells overexpressing each mutant hGDD1 protein, but not the wild-type hGDD1 protein, decreased cell adhesion and changed the cell morphology to a round shape ( fig. 4C ). However, these rounded cells showed
Figure 3
Expression analysis of GDD1 mRNA in human and mouse tissues. A, A human Multiple Tissue Northern Blot (Clontech), hybridized with a 32 P-labeled 581-bp fragment of hGDD1 cDNA (upper panel). The blot was rehybridized with 32 P-labeled b-actin cDNA as a loading control (lower panel). B, RT-PCR analysis for hGDD1 mRNA in human tissues, normal human osteoblasts, and normal human periodontal ligament cells. We used osteoblasts isolated from jawbone specimens (hOB1-4) by use of the explant culture method (Hahn et al. 1988) , osteoblasts from femur (hOB5 [Cambrex] ), and periodontal ligament cells (hPDL) isolated from extracted tooth by use of the explant culture method. These cells were maintained in a-minimum essential medium containing 10% fetal bovine serum, 50 mg/ml of L-ascorbic acid, 50 U/ml penicillin, and 50 mg/ml streptomycin, and used at passage 3-4 for extraction of total RNA. A 348-bp fragment of hGDD1 cDNA was amplified by use of primers from exons 9 and 12. PCR was performed by use of Platinum Taq (Invitrogen) at 95ЊC for 2 min, followed by 30 or 40 cycles of 94ЊC for 30 s, 55ЊC for 30 s, and 72ЊC for 30 s. A 452-bp fragment of hGAPDH cDNA was amplified as an internal control. C, Relative expression of mGDD1 (normalized to mGAPDH) in mouse tissues. A real-time, two-step RT-PCR analysis was performed by use of SYBR Green PCR Master Mix (Applied Biosystems) and the ABI Prism 7900HT system (Applied Biosystems). Total RNA was isolated from various tissues of mouse aged 8 wk and reverse transcribed into random-primed first-strand cDNA. Specific PCR primer sets for mGDD1 and mGAPDH were designed to avoid amplification of genomic DNA. The relative quantity was determined by the standard curve method, in which the standard curves were generated by 10-fold serial dilution of mouse skeletal muscle cDNA. The normalized values were derived from the ratio of the relative quantity of mGDD1 for each sample to that of mGAPDH for that sample. Data are presented as the means ‫ע‬ SD of three independent experiments. no features of apoptotic cell death, such as chromatin condensation or DNA fragmentation (data not shown).
In the present study, GDD1 mutations were identified in two families with different genetic backgrounds who were both affected with GDD. We believe that mutant alleles at GDD1 are responsible for the disease for several reasons, in addition to the fact that the gene maps to the critical region. In each of the two families, mutant alleles of GDD1 cosegregated with the disease phenotype. Both missense mutations involved the cysteine residue at amino acid 356, which is evolutionarily conserved in human, mouse, zebrafish, fruit fly, and mosquito, further suggesting the biological significance of these mutations. None of the mutations was observed in normal chromosomes. hGDD1 was shown to be expressed in human osteoblasts and periodontal ligament cells, consistent with the disease phenotype and the previous studies suggesting that cemento-osseous lesions of the jaws originate in the periodontal ligament (Waldron and Giansanti 1973; Neville and Albenesius 1986) . In mouse, mGDD1 mRNA was shown to be abundant in fresh bone tissues.
Although hGDD1 seemed to be an integral membrane protein localizing in the ER, its function remains unknown. As a clue to the function, membrane proteins localizing in the ER are often involved in protein pro-
Figure 4
Expression of the hGDD1 protein in COS-7 cells. A, Western blot analysis to confirm expression of the wild-type and mutant hGDD1 proteins. Whole-cell lysates from COS-7 cells transfected with each plasmid expression vector containing the wild-type (hGDD1-V5) or mutant (C356R or C356G) hGDD1 cDNA tagged with V5 epitope at its 3 end were subjected to reducing SDS-PAGE, and western blot analysis was performed by use of anti-V5 antibody (Invitrogen). For control transfection, pcDNA6/lacZ-V5 (Invitrogen) was used to represent the expression of an unrelated exogenous protein. B, Cellular localization of the wild-type hGDD1 protein. V5-tagged hGDD1 protein (hGDD1-V5) formed a distinct reticular pattern around the nucleus (green). Costaining with antibody against the calreticulin ERspecific marker (red) showed colocalization with the hGDD1 protein (yellow). C, Immunofluorescent staining with anti-V5 antibody, which shows that the only cells overexpressing each mutant hGDD1 protein decrease cell adhesion and change the cell morphology to a round shape.
cessing, protein folding, or calcium homeostasis. The amino acid sequence of hGDD1 lacks calcium or ATPbinding motifs and contains no homology to heat-shock proteins or GroEL, thereby providing no evidence for a direct involvement of hGDD1 in protein folding or calcium sequestration (Ma and Hendershot 2001) . Instead, the presence of eight predicted transmembrane-spanning domains suggests that hGDD1 might function in the transport of ions or other small molecules across membranes. We speculate that hGDD1 might function as an intracellular calcium-release channel and that it might regulate a calcium-dependent signaling pathway. Various substances that influence bone remodeling modify the intracellular calcium concentration in osteoblasts (Meszaros and Karin 1995) . There are two sources of intracellular calcium in osteoblasts: (1) inflow from the extracellular space and (2) release from intracellular stores, such as the ER. The release of calcium from the ER is a ubiquitous signal in many cells, including osteoblasts (Kumagai et al. 1991; Ljunggren et al. 1991) . Given that each mutant hGDD1 induces excess calcium release from the ER, the alteration in cell shape (as described above) could occur through modulation of the cytoskeleton (Pettit and Fay 1998) . Further studies of the function of hGDD1 should yield crucial insights into the pathogenesis of GDD.
